文献速递胰腺与胆道疾病

喷他佐辛(κ阿片受体激动剂)在急性胰腺炎镇痛中优于双氯芬酸:一项随机对照试验

Pentazocine, a Kappa-Opioid Agonist, Is Better Than Diclofenac for Analgesia in Acute Pancreatitis: A Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

该双盲随机对照试验将50例急性胰腺炎患者随机分为喷他佐辛30 mg组(24例)和双氯芬酸75 mg组(26例),芬太尼经患者自控镇痛泵作为补救镇痛。喷他佐辛组补救芬太尼剂量显著更低、无痛期更长,不良事件两组相似。

要点

  • 喷他佐辛组补救芬太尼剂量126 μg(IQR 65-218 μg)低于双氯芬酸组225.5 μg(IQR 133-427 μg),P=0.028。
  • 喷他佐辛组无痛期31.1±8.2小时长于双氯芬酸组27.9±6.6小时,P=0.047。
  • 两组不良事件相似,有效与无效需求次数差异未达统计学显著(P=0.098)。

核心结论

  • 喷他佐辛(κ阿片受体激动剂)在急性胰腺炎镇痛中显著优于双氯芬酸。

研究设计与样本

  • 双盲随机对照试验,共随机50例急性胰腺炎患者,喷他佐辛组24例,双氯芬酸组26例。
  • 干预为静脉双氯芬酸75 mg或喷他佐辛30 mg,芬太尼经患者自控镇痛泵作为补救镇痛。

主要发现

  • 补救镇痛药芬太尼剂量喷他佐辛组126 μg(IQR 65-218 μg)vs 双氯芬酸组225.5 μg(IQR 133-427 μg),P=0.028。
  • 无痛期喷他佐辛组31.1±8.2小时 vs 双氯芬酸组27.9±6.6小时,P=0.047。
  • 有效与无效需求次数喷他佐辛组11.5(IQR 8-15)vs 双氯芬酸组16(IQR 13-20),P=0.098,未达统计学显著。
  • 不良事件两组相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The ideal analgesic is not known for patients with acute pancreatitis (AP). Concerns have been raised about serious adverse effects of opioid analgesics increasing the severity of AP. We hypothesized that nonsteroidal anti-inflammatory drugs might be better analgesics because of their anti-inflammatory effect. Our objective was to compare pentazocine, an opioid, and diclofenac, a nonsteroidal anti-inflammatory drug, for adequate analgesia in patients with AP. METHODS: In a double-blind randomized controlled trial, patients with AP were randomized to either intravenous diclofenac 75 mg or pentazocine 30 mg. Fentanyl was given as a rescue analgesic through a patient-controlled analgesia pump. Primary outcome was pain relief measured objectively by the dose of fentanyl required as the rescue analgesic, pain-free period, and numbers of effective and ineffective demands of fentanyl. Secondary outcome was adverse events. RESULTS: Fifty patients were randomized, 24 to the pentazocine group and 26 to the diclofenac group. Baseline characteristics were comparable between the groups. Pentazocine was found to be better than diclofenac in terms of significantly lower dose of the rescue analgesic (fentanyl) required (126 μg (interquartile range (IQR) 65-218 μg) vs 225.5 μg (IQR 133-427 μg); P = 0.028) and longer pain-free period (31.1 ± 8.2 vs 27.9 ± 6.6 hours, P = 0.047). The number of effective and ineffective demands was lower in the pentazocine group compared with the diclofenac group (11.5 (IQR 8-15) vs 16 (IQR 13-20), P = 0.098) although not statistically significant. Adverse events were similar between the groups. CONCLUSIONS: Pentazocine, a kappa-opioid receptor agonist, was significantly better than diclofenac for pain relief in AP (Trial registration number: CTRI/2016/09/007326).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Mahapatra SJ, Jain S, Bopanna S, et al. Pentazocine, a Kappa-Opioid Agonist, Is Better Than Diclofenac for Analgesia in Acute Pancreatitis: A Randomized Controlled Trial. Am J Gastroenterol. 2019. PMID: 31008736. doi:10.14309/ajg.0000000000000224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。